Your session is about to expire
← Back to Search
Cognitive Behavioural Therapy for Inflammatory Bowel Disease (iCBT Trial)
iCBT Trial Summary
This trial will compare an internet-based cognitive behavioural therapy intervention to usual care in reducing stress, anxiety, and depression for people with Inflammatory Bowel Disease and comorbid anxiety and/or depression.
iCBT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowiCBT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iCBT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had thoughts about hurting yourself or have been struggling with substance abuse, mental disorders like psychosis or eating disorders within the last six months.I am not currently in, nor have I been in the last 3 months, cognitive behavioral therapy for anxiety or mood disorders.I am 18 years old or older.I have been diagnosed with IBD (Crohn's disease or Ulcerative Colitis).My mental health medication dose has been stable for at least 6 weeks.My anxiety or depression score is above 8.We will determine if you have certain behaviors or disorders during the screening process explained in the next section.
- Group 1: Intervention Group
- Group 2: Treatment as Usual
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any open vacancies for participants in this experiment?
"Clinicaltrials.gov lists this medical study as still actively recruiting participants, which it has been doing since March 16 2021 - the date of its initial posting. It was last updated on March 28 2022."
What aims does this experiment seek to fulfill?
"This trial will assess the effectiveness of PSS-4 as primary outcome over baseline, 6 weeks, 12 weeks and 24 weeks. Other objectives include tracking Change in Clinical Global Impression - Improvement scale (CGI-I), Inflammatory Bowel Disease Symptom Inventory - Short Form (IBDSI) severity levels and Work and Social Adjustment Scale (WSAS) functionality impacts through likert scales with varying anchor points. Higher scores indicate higher stress or functional impairment from IBD symptoms respectively."
How many subjects are included in this research endeavor?
"Affirmative. The details listed on clinicaltrials.gov denote that this experiment is accepting participants at the moment and was originally posted on March 16th 2021, with the latest amendment being made on March 28th 2022. Accordingly, 352 volunteers are necessary from a single facility."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger